2022 Significant Developments in the Tobacco Industry and What to Expect in 2023 (Part One)

Regulatory Oversight Podcast


In this episode, Stephen Piepgrass and his guests review what happened over the past year and offer thoughts on what to expect in the months ahead.

The U.S. tobacco industry is subject to a variety of regulators at the federal and state level. In this first of a two-part series focused on significant regulatory developments in the tobacco industry, Stephen Piepgrass is joined by colleagues Bryan Haynes, Agustin Rodriguez and Nick Ramos to review what happened over the past year, and offer thoughts on what to expect in the months ahead. Our panel discusses federal regulations including important developments at the FDA, such as leadership changes, the pre-market review process, and actions on non-tobacco nicotine products. They also touch on the premium cigar industry's challenge to FDA's warning label requirement; the tobacco industry's challenge to FDA's graphic cigarette warning label rule; and a court order that resolved the government's long-running civil racketeering lawsuit against the largest U.S. cigarette companies. Be on the lookout for part two of the podcast series.


Stephen C. Piepgrass Partner Email 804.697.1320
Bryan M. Haynes Partner Email 804.697.1420
Agustin E. Rodriguez Partner Email 804.697.1381
Nicholas Ramos Associate Email 804.697.1866
Related practices and industries
Lobbying + Public Affairs, State Attorneys General, White Collar + Government Investigations